[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Xie Mingxing\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":80},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,36,58],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":29,"completionDateStruct":31,"leadSponsor":33,"locationsCount":4},"100437750","multimodal-imaging-evaluation-and-prognostic-analysis-of-participants-after-arterial-switch-operation-100437750",false,"NCT04980339","Multimodal Imaging Evaluation and Prognostic Analysis of Participants After Arterial Switch Operation","Multimodal Imaging Evaluation and Prognostic Analysis of Participants With Transposition of the Great Arteries After Arterial Switch Operation: a Multi-site Clinical Study","Inclusion Criteria:\n\n·Participants with the diagnosis of TGA or TBA underwent ASO.\n\nExclusion Criteria:\n\n* Patients with various forms of TGA undergoing Réparation à l'Etage Ventriculaire procedure\n* Patients with various forms of TGA undergoing Rastelli procedure\n* Patients with various forms of TGA undergoing Nikaidoh procedure\n* Patients with various forms of TGA undergoing Fontan operation\n* Patients with various forms of TGA undergoing atrial repair (Mustard or Senning) operations\n* ASO is used as a corrective therapy for prior operations.","ALL",{"count":18,"type":19},1000,"ESTIMATED","OBSERVATIONAL","The aims of this study are to\n\n1. Identify the early and midterm outcomes in terms of mortality and reoperation of the arterial switch operation (ASO).\n2. Identifying the influence of coronary artery anomalies on the in-hospital and post-discharge prognosis after ASO.\n3. Evaluate the predictors for neoaortic valve regurgitation after ASO.\n4. Explore the risk factors for neopulmonary artery stenosis after ASO.",[23],"Arterial Switch Operation","NOT_YET_RECRUITING","2022-07-12",{"date":27,"type":28},"2022-07-13","ACTUAL",{"date":30,"type":19},"2022-10-01",{"date":32,"type":19},"2032-10-31",{"name":34,"class":35},"Xie Mingxing","OTHER",{"id":37,"slug":38,"hasResults":11,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":4,"eligibilityCriteria":42,"healthyVolunteers":43,"sex":16,"minAge":44,"maxAge":45,"enrollmentInfo":46,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":48,"conditions":49,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":52,"startDateStruct":53,"completionDateStruct":55,"leadSponsor":57,"locationsCount":4},"100436550","a-multicenter-clinical-study-of-echocardiographic-assessment-of-right-heart-function-and-implications-of-prognosis-in-diabetes-100436550","NCT04964713","A Multicenter Clinical Study of Echocardiographic Assessment of Right Heart Function and Implications of Prognosis in Diabetes","A Multicenter Clinical Study of Echocardiographic Assessment of Right Heart Function and Implications of Prognosis in Diabetes Mellitus","Inclusion Criteria:\n\npeople with T2DM according to the WHO 2006 criteria\n\nExclusion Criteria:\n\nincluding history or symptoms of CAD valvular heart disease, rhythm disturbances cardiomyopathy congenital heart disease symptomatic heart failure pulmonary disease",true,"35 Years","79 Years",{"count":47,"type":19},2300,"The aims of this study are to 1. Evaluate the right heart structure and function in T2DM and Prediabetes patients by speckle tracking echocardiography, and to further investigate the influence of left heart on right heart structure and function in T2DM and Prediabetes patients. 2. To explore the prognostic value of right ventricular function in T2DM patients.",[50,51],"Diabetes","Prognosis",{"date":27,"type":28},{"date":54,"type":19},"2023-12-01",{"date":56,"type":19},"2031-12-31",{"name":34,"class":35},{"id":59,"slug":60,"hasResults":11,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":4,"eligibilityCriteria":64,"healthyVolunteers":11,"sex":16,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":68,"studyType":20,"phases":4,"briefSummary":69,"conditions":70,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":4},"100436724","multimodal-imaging-evaluation-and-prognostic-analysis-of-cardiac-allograft-vasculopathy-in-heart-transplantation-100436724","NCT04966988","Multimodal Imaging Evaluation and Prognostic Analysis of Cardiac Allograft Vasculopathy in Heart Transplantation","Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","Inclusion Criteria:\n\n• Heart transplantation after January 1st, 2015.\n\nExclusion Criteria:\n\n•Age \\\u003C 18 years at the time of transplantation; Died within 48 h; Heart-lung transplantation; Heart\u002Fkidney transplantation; Re-transplanted within 7 days after transplantation.","18 Years","80 Years",{"count":18,"type":19},"10 Years","The aim is to (1) establish a system of multimodal imaging technology; (2) jointly apply multimodal imaging technology to diagnose of cardiac allograft vasculopathy of heart transplantation; (3) construct a multimodal imaging technology prediction model of adverse events, screening the best non-invasive imaging prediction indicators.",[71],"Heart Transplant","2021-07-16",{"date":74,"type":28},"2021-07-19",{"date":76,"type":19},"2021-08-01",{"date":78,"type":19},"2026-08-01",{"name":34,"class":35},""]